Medical News

RSS

Positive results from Factor IX-CTP comparative study in hemophilic mice

PROLOR Biotech, today reported positive results from a comparative study of its biobetter longer-acting version of the hemophilia drug Factor IX in Factor IX-depleted hemophilic mice.

3 Feb 2011

Scientists challenged to sequence genome and RNA content derived from single cancer cell

Life Technologies Corporation today announced that the Life Grand Challenges Contest, initially introduced in December 2010, is expanding to include a fourth challenge. This latest contest challenges scientists to sequence the genome and all RNA content derived from a single cancer cell using the 5500 Series SOLiD™ Sequencers.

3 Feb 2011

EGEN receives 4-year, $1.6M FDA grant for EGEN-001 Phase II clinical study in ovarian cancer

EGEN, Inc. today announced that the Food and Drug Administration (FDA) has awarded the company a four-year grant of $1,600,000 to assist in the Phase II clinical development of EGEN-001, the company's lead product. EGEN-001 is under clinical development for the treatment of advanced recurrent ovarian cancer.

2 Feb 2011

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

For women seeking pregnancy by assisted reproductive technologies, such as in-vitro fertilization, a new study shows that the health of the uterus is more relevant than egg quality for a newborn to achieve normal birth weight and full gestation.

2 Feb 2011

Analyzing the health law's 'prognosis'

As experts continue to parse the specifics of a federal Judge's Monday ruling striking down the health overhaul, experts speculate about what the Supreme Court could decide. Meanwhile, insurers, health industry stakeholders and even state officials mull their next steps.

2 Feb 2011

Isis commences ISIS-FXIRx Phase 1 study for treatment of clotting disorders

Isis Pharmaceuticals, Inc. announced the initiation of a Phase 1 study of ISIS-FXIRx, an antisense drug designed to treat clotting disorders. ISIS-FXIRx inhibits the production of Factor XI, a clotting factor that is an important component of the coagulation pathway. Because of its role in the intrinsic coagulation pathway, inhibition of Factor XI could offer an effective approach for preventing the formation of blood clots with a lower risk of bleeding.

2 Feb 2011

Legal decision triggers political twists

News outlets report on some of the political issues surrounding the individual mandate and Monday's legal decision striking down the health law.

2 Feb 2011

USPTO issues notice of allowance to Vermillion's breast cancer biomarkers

Vermillion, a molecular diagnostics company, today announced that the United States Patent and Trademark Office has issued a notice of allowance for a patent entitled "Biomarkers for breast cancer" to the Company.

2 Feb 2011

New study: Clinical trials exclude older patients due to age-related conditions

Older individuals, who constitute a rapidly growing population in the United States, account for a disproportionate share of health care utilization and cost. Yet more than half of clinical trials exclude people based on their age or age-related conditions, according to a new study by Robert Wood Johnson Foundation Clinical Scholars- at the University of Michigan.

2 Feb 2011

Researchers discover potential vaccine capable of reducing H. pylori colonization

A new study led by researchers at Rhode Island Hospital in collaboration with the University of Rhode Island and EpiVax. Inc, a privately owned vaccine development company in Providence, RI, has identified a potential vaccine capable of reducing colonization of Helicobacter pylori -- a known cause of gastritis, ulcer disease and cancer.

2 Feb 2011

Scil Proteins concludes financing round with BioNet Holding for €24 million

Scil Proteins today announced that it has concluded a financing round with its existing investor, BioNet Holding, worth €24 million. The funds are intended to finance the development of two products derived from the Company's Affilin platform into clinical Phase I over the next three years.

2 Feb 2011

Study: Simple sideline test can accurately detect concussions in athletes

A simple test performed at the sideline of sporting events can accurately detect concussions in athletes, according to study by researchers at the University of Pennsylvania School of Medicine. Current sideline tests can leave a wide amount a brain function untested following concussion.

2 Feb 2011

Five young scientists receive Damon Runyon-Rachleff Innovation Award for cancer research

The Damon Runyon Cancer Research Foundation announced that five scientists with novel approaches to fighting cancer have been named 2011 recipients of the Damon Runyon-Rachleff Innovation Award. The grant of $450,000 over three years is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer.

2 Feb 2011

FDA approves FSS's FlexStent system IDE for OPEN Trial

Flexible Stenting Solutions, a leading developer of next generation peripheral arterial, venous, neurovascular and biliary stents, announced today that it has received full FDA Investigational Device Exemption approval for its FlexStent Femoropopliteal Self Expanding Stent System.

2 Feb 2011

Cutera launches Excel V laser system for Dermatologists and Plastic Surgeons

Cutera, a leading worldwide provider of laser and other energy-based aesthetic systems for practitioners worldwide, today announced the launch of its Excel V laser system ─ a unique vascular work station designed specifically for the core-market of Dermatologists and Plastic Surgeons.

2 Feb 2011

Cell Press launches new iPhone application for downloading research articles

Cell Press is delighted to announce the launch of its new iPhone app - Cell Alerts, available to download for free at www.cell.com/iphone or http://bit.ly/fw9pbx.

2 Feb 2011

Federal judge's ruling could lead to new, patient-focused reforms to American health care system

Coalition to Protect Patients' Rights (CPPR) spokesman, Dr. Donald J. Palmisano, today said that a federal judge's ruling on the unconstitutionality of the Affordable Care Act's individual mandate could lead to new, patient-focused reforms to the American health care system.

2 Feb 2011

Damaged heart rebuilt with heart stem cells from children with congenital heart disease

A new study, revealing that heart stem cells from children with congenital heart disease were able to rebuild the damaged heart in the laboratory, could provide a new outlet for Emerging Healthcare Solutions' NASA bioreactor.

2 Feb 2011

Effective methods to change physician behavior and improve compliance to guidelines

When it comes to changing the way physicians practice, guidelines and educational initiatives alone are not effective. An editorial by James A. Arrighi, M.D., a cardiologist with Rhode Island Hospital, explains the effective methods to change physician behavior and improve compliance to guidelines. The editorial is published online in advance of print of the February 8 edition of the American Heart Association's journal Circulation.

2 Feb 2011

2010 Dietary Guidelines urge Americans to keep calorie intake from saturated fat to less than 10%

This week the U.S. government released the 2010 Dietary Guidelines for Americans with few changes since the 2005 version. The guidelines continue to urge Americans to keep their calorie intake from saturated fat to less than 10 percent and lower the amount of trans fat in their diet to as low as possible.

2 Feb 2011

Medical News

Positive results from Factor IX-CTP comparative study in hemophilic mice

Scientists challenged to sequence genome and RNA content derived from single cancer cell

EGEN receives 4-year, $1.6M FDA grant for EGEN-001 Phase II clinical study in ovarian cancer

Uterine health is more relevant for fetus to achieve normal birth weight, full gestation

Analyzing the health law's 'prognosis'

Isis commences ISIS-FXIRx Phase 1 study for treatment of clotting disorders

Legal decision triggers political twists

USPTO issues notice of allowance to Vermillion's breast cancer biomarkers

New study: Clinical trials exclude older patients due to age-related conditions

Researchers discover potential vaccine capable of reducing H. pylori colonization

Scil Proteins concludes financing round with BioNet Holding for €24 million

Study: Simple sideline test can accurately detect concussions in athletes

Five young scientists receive Damon Runyon-Rachleff Innovation Award for cancer research

FDA approves FSS's FlexStent system IDE for OPEN Trial

Cutera launches Excel V laser system for Dermatologists and Plastic Surgeons

Cell Press launches new iPhone application for downloading research articles

Federal judge's ruling could lead to new, patient-focused reforms to American health care system

Damaged heart rebuilt with heart stem cells from children with congenital heart disease

Effective methods to change physician behavior and improve compliance to guidelines

2010 Dietary Guidelines urge Americans to keep calorie intake from saturated fat to less than 10%

Exploring the nanoscale: How AFM is transforming cosmetic science

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

Latest News